Gilead’s Research Scholars Program in Oncology Solid Tumors

The Research Scholars Program supports innovative research from emerging investigators around the world to incorporate new perspectives in our pursuit of scientific understanding and progress. We believe that new voices and research topics are needed to advance scientific knowledge in areas of unmet medical need and create a healthier world. The program is designed to support any pre-clinical and clinical research limited to breast, bladder, or lung cancer that addresses an unmet medical need in the field of Oncology Solid Tumors.

The Research Scholars Program is actively working towards reducing potential barriers to entry and success for applicants from population groups who are typically underrepresented in research. We are committed to supporting researchers and research projects addressing unmet patient needs and health inequities in order to build a more inclusive research landscape.

Gilead’s Research Scholars Program selects junior faculty researchers pursuing an academic career at an institution at the time of application of up to $180,000 USD paid directly to the researchers’ institution in 2 annual instalments subject to Program terms and conditions, legal requirements, and applicable institutional rules.

Scientific Focus
The program is designed to support any pre-clinical and clinical research focused on breast, bladder, or lung cancer that addresses an unmet medical need in the field of Oncology Solid Tumors, in Australia, Canada, and Europe. This may include, but is not limited to, research focused on:

  • Disparities and inequities in cancer care
  • Agnostic approaches to solid tumors
  • Combinational drug strategies/approaches to treatment
  • Resistance mechanism identification/novel approaches to addressing resistance mechanisms
  • Transformative, therapeutic modalities/approaches to treatment
  • Patient-specific factors that are predictors of toxicity
  • Genomic polymorphisms and impact treatment response
  • Novel targets and/or biomarkers/imaging techniques
  • Novel diagnostic, prevention and treatment strategies
  • Research to improve Quality of Life (QoL) Patient-Reported Outcomes (PRO’s) e.g., adverse events, addressing unmet needs for patients
  • Any other pre-clinical and clinical research that addresses an unmet medical need or gap in scientific knowledge
Eligibility Criteria
Applicants must meet the following requirements:
  • Hold an MD, or PhD, (or equivalent degree) at time of award. MD qualifications would have to have been obtained within the last 10 years and PhD qualifications would have to have been obtained within the last 5 years
  • Early to Mid-career scientists with a strong research track record who hold a position as a recognised research institution in one of the eligible countries at the time of application and whose tenure of that position encompasses the projected period of the award from the Gilead scholarship program
  • Have a strong career interest in Oncology Solid Tumors
  • Have a research mentor with extensive experience in the field of Oncology Solid Tumors
  • Be able to devote at least 30% of their professional time to research for the next two years (versus administrative, patient care, or teaching responsibilities)
  • Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) resulting from the research
Click to Download Program Brochure

For more information regarding the program, please visit the Research Scholars Program Solid Tumors Portal

Feedback to Applicants
The Scientific Review Committee oversees the program independently from Gilead when reviewing applications and making awardee selections. Scholars retain their independence from Gilead as well.

All applications are reviewed by two Scientific Review Committee members. The highest scoring applications will then be discussed at length by all Scientific Review Committee members at a review meeting. The awardees and runners up are then selected by consensus of the committee.

All applications that make it through to this final stage are deemed highly competitive and will receive feedback outlining their research proposals strengths and areas for development regardless of whether they are selected for an award.

Gilead’s Research Scholars Program is committed to building a more diverse and inclusive scientific community. Award selections are made without discrimination based on ethnicity, race, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression.

GILEAD and the GILEAD Logo are trademarks of Gilead Sciences, Inc. All other trademarks referenced herein are the property of their respective owners. ©2023 Gilead Sciences, Inc. All rights reserved.

Leave a Reply